Examine Disruptions in Specialty Drug Distribution and the Impact on Access, Quality and Cost
- Las Vegas, NV
CBI’s Specialty Therapies is back for the 16th year! Join the healthcare community in Las Vegas to tackle the challenges of paying for innovative therapies that are conquering or controlling diseases that were once considered untreatable. Payers, specialty pharmacies and pharmaceutical executives will gather for an open exchange of ideas on the latest challenges and trends. Discussions will focus on how to control costs while increasing patient satisfaction and adherence.
With a range of topics that include adapting value-based design strategies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, the biosimilars pipeline and anticipated access barriers, comparing drug channels for therapies, and paying for high-tech therapies, you won’t want to miss it!
Featuring Robust Discussions On:
- Investigate how distribution channels for specialty therapies are changing and the impact on cost, access and health outcomes
- Understand how in-house specialty pharmacies can enable health systems to accelerate a patient’s speed-to-therapy and improve quality of care through integrated clinical coordination
- Evaluate the potential impact of the removal of safe harbor for
drug rebates - Consider how distribution channels that accommodate 340B hospital pharmacies, PBMowned pharmacies, limited distribution drugs, any willing provider legislation and closed specialty networks affect
clinical outcomes and costs - Unravel the complexities within Copay Accumulator Programs and how they will affect specialty therapy utilization rates and
long-term medical spend
WHAT THE INDUSTRY IS SAYING:
I found the program to be well-designed
Executive Director, MidAtlantic Business Group on Health
and stimulating, well worth my time.
Class act!
Director, Specialty Pharmacy Programs, BlueCross BlueShield South Carolina
The specialty pharmacy arena is constantly evolving.
Director, Clinical Pharmacy, BlueCross BlueShield Tennessee
Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOLs and prepare for the challenges that they are currently
dealing with or will be facing in the near future.
Specialty Therapies 2019
Examine Disruptions in Specialty Drug Distribution and the Impact on Access, Quality and Cost
CBI’s Specialty Therapies is back for the 16th year! Join the healthcare community in Las Vegas to tackle the challenges of paying for innovative therapies that are conquering or controlling diseases that were once considered untreatable. Payers, specialty pharmacies and pharmaceutical executives will gather for an open exchange of ideas on the latest challenges and trends. Discussions will focus on how to control costs while increasing patient satisfaction and adherence.
With a range of topics that include adapting value-based design strategies, interfacing between ICER and pharmaceutical manufacturers and the effects on formulary decision making, the biosimilars pipeline and anticipated access barriers, comparing drug channels for therapies, and paying for high-tech therapies, you won’t want to miss it!
Featuring Robust Discussions On:
- Investigate how distribution channels for specialty therapies are changing and the impact on cost, access and health outcomes
- Understand how in-house specialty pharmacies can enable health systems to accelerate a patient’s speed-to-therapy and improve quality of care through integrated clinical coordination
- Evaluate the potential impact of the removal of safe harbor for
drug rebates - Consider how distribution channels that accommodate 340B hospital pharmacies, PBMowned pharmacies, limited distribution drugs, any willing provider legislation and closed specialty networks affect
clinical outcomes and costs - Unravel the complexities within Copay Accumulator Programs and how they will affect specialty therapy utilization rates and
long-term medical spend
WHAT THE INDUSTRY IS SAYING:
I found the program to be well-designed
Executive Director, MidAtlantic Business Group on Health
and stimulating, well worth my time.
Class act!
Director, Specialty Pharmacy Programs, BlueCross BlueShield South Carolina
The specialty pharmacy arena is constantly evolving.
Director, Clinical Pharmacy, BlueCross BlueShield Tennessee
Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOLs and prepare for the challenges that they are currently
dealing with or will be facing in the near future.
